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Cancer is a human tragedy that strikes and kills the lives of our beloved people. With a 
limited number of effective anticancer drugs from natural resources currently in use, there 
is a real need for new, safe, cheap and effective anticancer drugs to combat this dreaded 
and formidable disease. Plants have a long history of use in the treatment of cancer. 
Several plant-derived anticancer agents including taxol, vinblastine, vincristine, the 
camptothecin derivatives, topotecan and irinotecan and etoposide derived from epi-
podophyllotoxin are in clinical use all over the world.  
 
In this study, two endemic plant species from the Rubiaceae and Asteraceae families, 
namely Anthospermum hispidulum E.Mey. ex Sond. and Eriocephalus tenuifolius DC.  
were investigated for their anticancer properties. The organic (methanol/dichloromethane, 
1:1 v/v) extracts of both plant species were found to have moderate anticancer activity 
against a panel of three human cancer cell lines namely, breast MCF7, renal TK10 and 
melanoma UACC62 at the CSIR anticancer screen. Bioassay-guided fractionation of the 
organic extracts of Anthospermum hispidulum led to the isolation of an active compound 
which was characterised as ursolic acid. Another compound, namely scopoletin was also 
isolated. The compounds isolated here are known compounds, but have not previously 
been reported as present in the genus Anthospermum. 
 
Bioassay-guided fractionation of the organic extracts of Eriocephalus tenuifolius resulted 
in the isolation of 8-O-isobutanoylcumambrin B as the active constituent. This compound 
is reported to have been isolated from related plant species; however its biological activity 
is not known. The compounds pectolinagenin, hispidulin, friedelinol and tetracosanoic acid 
were also isolated, but did not show any significant anticancer activity. The structures of 
all compounds isolated in this study were elucidated using nuclear magnetic resonance 
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For decades, natural products have been a source of drugs and drug leads. According to a 
recent survey by Newman and Cragg (2007) of the United States National Cancer Institute 
(NCI), 63% of the 974 small molecule new chemical entities introduced as drugs 
worldwide during the period 1981-2006 can be traced to or were inspired by natural 
products. Examples of important drugs obtained from plants are digoxin (1.1) from 
Digitalis purpurea (Fig. 1.1), quinine (1.2) and quinidine (1.3) from Cinchona officinalis 
(Fig. 1.2), vincristine (1.4) and vinblastine (1.5) from Catharanthus roseus (Fig. 1.3), 
atropine (1.6) from Atropa belladonna (Fig. 1.4) and codeine (1.7) and morphine (1.8) 
from Papaver somniferum (Fig. 1.5). It is estimated that 60% of anti-tumour and anti-
infectious drugs already on the market or under clinical trial are of natural origin (Rates 
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Figure 1.2: Structures of quinine (1.2) and quinidine (1.3) from Cinchona officinalis 






































Figure 1.4: Structure of atropine (1.6) from Atropa belladonna 
Source: http://upload.wikimedia.org/wikipedia/commons/thumb/3/31/Atropa_belladonna _220605.jpg/684px-
Atropa_belladonna_220605.jpg 
1.2 R1 = H, R2 = OH
1.3 R1 = OH, R2 = H
1.4 R = CH3
















The search for anticancer agents from plant sources began in the 1950’s at the United 
States National Cancer Institute (NCI) and the NCI has since made major contributions to 
the discovery of new naturally occurring anticancer agents. In spite of the success of the 
natural products approach to anticancer drug discovery, reports on plants used for the 
treatment of cancer are rare in South Africa (Steenkamp and Gouws 2006). As a result, a 
collaborative research programme was initiated between the Council for Scientific and 
Industrial Research (CSIR) in South Africa and the NCI, aimed at the screening of plant 
extracts and identification of potentially new anticancer drug leads. 
 
An anticancer screening technology was implemented at the CSIR in 1999 with a panel of 
three human cancer cell lines namely, breast MCF7, renal TK10 and melanoma UACC62. 
These cell lines were selected because of their high sensitivity to detect anticancer activity. 
 
Plant extracts that exhibit anticancer activity against these three human cell lines are then 
screened by the NCI against sixty cell lines organized into sub-panels representing 
leukaemia, melanoma, cancer of the lung, colon, kidney, ovary and central nervous system. 
 
Two endemic plants from the Rubiaceae and Asteraceae families, namely Anthospermum 
hispidulum E.Mey. ex Sond. and Eriocephalus tenuifolius DC., respectively, were 
investigated as part of this research programme and their organic extracts were found to 
have moderate anticancer activity against the panel of three human cancer cell lines at the 
CSIR. 
 
1.7 R = H
1.8 R = CH3
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The aims of this study were:  
 To screen extracts of Anthospermum hispidulum and Eriocephalus tenuifolius for 
anticancer activity. 
 To isolate and purify compounds from the active organic extracts of A. hispidulum 
and E. tenuifolius.  
 To elucidate structures of the isolated compounds using nuclear magnetic 
resonance spectroscopy (NMR) and mass spectrometry (MS) techniques. 
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2.1 What is cancer? 
 
Cancer is the generic term for a group of diseases characterized by uncontrolled growth 
and proliferation of abnormal cells. If the spread is not controlled, it can result in death. 
Cancer is caused by both external factors (tobacco, chemicals, radiation and infectious 
organisms) and internal factors (inherited mutations, hormones, immune conditions and 
mutation that occur from metabolism) (Fig. 2.1). These causal factors may act together or 
in sequence to initiate or promote carcinogenesis. Most cancers can be treated and some 
cured, depending on the specific type, location and stage. The main treatments are surgery, 
radiation therapy, chemotherapy, hormone therapy, biological therapy and targeted therapy 
(American Cancer Society 2007).  
 
 
Figure 2.1: Causes of cancer (Beliveau and Gingras 2007) 
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There are more than 100 different types of cancer, which are grouped into five major 
categories: 
 Carcinoma – cancer that originates in the skin or in tissue that line or cover 
internal organs. For example, breast, prostate, lung and colon cancer. 
 Sarcoma - cancer that originates in supportive and connective tissues such as 
bones, cartilage, fat, muscle and blood vessels. 
 Leukemia - cancer that starts in blood-forming tissue such as the bone marrow and 
causes large numbers of abnormal blood cells to be produced and enter the blood. 
 Lymphoma and myeloma - cancers that originate in the cells of the immune 
system. 
 Central nervous system cancers - cancers that begin in the tissues of the brain and 
spinal cord. 
Most cancers are named for the organ or type of cell in which they originate. For example, 
cancer that begins in the breast is called breast cancer (National Cancer Institute 2007).  
 
According to the Cancer Association of South Africa (2005), South African men and 
women, in order of prevalence, are affected by the following cancers: 
Women: 
Breast cancer; cervical cancer; colo-rectal cancer; lung cancer and oesophageal cancer 
Men:  
Prostate cancer; lung cancer; oesophageal cancer; bladder cancer and colo-rectal cancer 
 
 
2.2 Cancer and its impact 
 
Cancer is a growing public health problem worldwide. It affects all people irrespective of 
age, gender, race and socio-economic status. More than 11 million people are diagnosed 
with cancer every year. It is estimated that there will be 16 million new cases every year by 
2020. About 12.5% of all deaths worldwide are caused by cancer. That is more than the 
percentage of deaths caused by HIV/AIDS, tuberculosis and malaria put together (World 




Chronic diseases, including cancer, are on the increase internationally and in South Africa, 
due to unhealthy lifestyle habits. In South Africa approximately 1 in 4 people may become 
a cancer statistic in their lifetime and almost everyone knows someone who has been 
affected by the disease. 
 
Cancer has long been the second leading cause of death in the United States of America 
after heart disease, accounting for about a quarter of all deaths. About 1,444,920 new 
cancer cases are expected to be diagnosed in 2007 (this figure does not include non-
invasive cancers) and about 559,650 Americans are expected to die of cancer this year. 
 
The National Institute of Health (NIH) has estimated the costs from cancer in 2006 to be 
206.3 billion US dollars. It is also important to note that 77% of all cancers diagnosed are 
in people 55 years of age or older (American Cancer Society 2007). With cancer taking 
such a toll on the population, both in lives and cost, the discovery of effective anticancer 
drugs has become very important. 
 
 
2.3 Plants as a source of anticancer agents 
 
Over 60% of currently used anticancer agents are derived in one way or another from 
natural sources, including plants, marine organisms and micro-organisms (Rates 2001; 
Newman et al. 2003; Cragg et al. 2005; McChesney et al. 2007). Plants have a long history 
of use in the treatment of cancer (Hartwell 1982). In his review, Hartwell lists more than 
3000 plant species that have reportedly been used in the treatment of cancer. Graham et al. 
(2000) had also added another 350 plant species to Hartwell’s list. These statistics clearly 
demonstrate the importance and potential of plants as a primary source for drug discovery 
and development. 
 
Well-known examples of the plant-derived anticancer drugs in clinical use or development 
are the so-called vinca alkaloids, vinblastine (2.1) and vincristine (2.2), which are isolated 
from the Madagascar periwinkle, Catharanthus roseus. C. roseus is used by various 
cultures for the treatment of diabetes, and vinblastine (2.1) and vincristine (2.2) were first 
discovered during an investigation of the plant as a source of potential oral hypoglycaemic 
agents (Schwartsmann et al. 2002; Cragg and Newman 2003; Kintzios 2006).  
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Vinblastine (2.1) has been shown to be a very effective treatment for Hodgkin’s disease 
and has also been used to treat breast cancer, Kaposi’s sarcoma and other diseases. It was 
also found to be the first drug of choice in the treatment of many forms of leukaemia and 
since the 1950s it has increased the survival rate of childhood leukemias by 80%. 
Vincristine (2.2) is widely used, in combination with other anticancer agents, in the 
treatment of acute lymphocytic leukaemia in children, and for certain lymphomas and 
sarcomas, small cell lung cancer, cervical and breast cancer (Hostettmann et al. 2000; 























2.1 Vinblastine, R= CH3,  
2.2 Vincristine, R= CHO  
 
The two clinically active agents, etoposide (2.3) and teniposide (2.4), which are semi-
synthetic derivatives of the natural product epipodophyllotoxin, may be considered being 
more closely linked to a plant originally used for the treatment of cancer. 
Epipodophyllotoxin is an isomer of podophyllotoxin (2.5), which was isolated as the active 
antitumor agent from the roots of various species of the genus Podophyllum. Etoposide 
(2.3) is used in the treatment of small cell lung cancer, testicular cancer, Kaposi’s sarcoma, 
lymphoma and leukaemia, while teniposide (2.4) has proved to be active against acute 
lymphatic leukaemia and neuroblastoma, non-Hodgkin’s lymphoma and brain tumours in 
































2.3 Etoposide, R = CH3,   2.5 Podophyllotoxin 




Another example of a plant-derived anticancer drug under clinical use is paclitaxel, more 
commonly known by its trademark name Taxol (2.6). Taxol, a complex terpene-based 
molecule isolated from the bark of the Pacific or American yew tree Taxus brevifolia is 
used in the treatment of refractory ovarian, breast and non-small cell lung cancer 
(NSCLC), and has also shown efficacy against Kaposi’s sarcoma. A paclitaxel analog, 



















































The clinically active agents, topotecan (2.8) and irinotecan (2.9) are semi-synthetically 
derived from camptothecin, isolated from the Chinese ornamental tree, Camptotheca 
acuminata. Topotecan (2.8) is used for the treatment of ovarian and small cell lung 
cancers, while irinotecan (2.9) is used in the treatment of metastatic colorectal cancer 























2.8 Topotecan     2.9 Irinotecan 
 
Other examples of plant-derived agents in clinical use are homoharringtonine (2.10), an 
alkaloid isolated from the Chinese tree, Cephalotaxus harringtonia var drupacea and 
elliptinium, a derivative of ellipticine (2.11), isolated from species of several genera of 
Apocynaceae family, including Bleekeria vitensis, a Fijian medicinal plant with reputed 
anticancer properties. Homoharringtonine has shown efficacy against various leukemias, 
while elliptinium is marketed in France for the treatment of breast cancer (Cragg and 


























2.10 Homoharringtonine   2.11 Ellipticine 
 
Examples of plant-derived anticancer agents in clinical development are the 
combretastatins (2.12), isolated from the bark of the South African “bush willow” tree, 
Combretum caffrum. These compounds are a family of stilbenes which act as 
antiangiogenic agents, causing vascular shutdowns in tumours and resulting in tumour 
necrosis when tested against solid tumours. Combretastatin A4 (2.13) has been found to 
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show strong cytotoxicity against a wide variety of human cancer cell lines, including 
multiresistant cancer cell lines. It is also stated that it is the most cytotoxic phytomolecule 
isolated so far. (Cragg and Newman 2005; Srivastava et al. 2005; Gurib-Fakim 2006; 

















2.12 Combretastatin  2.13 Combretastatin A4 
 
Flavopiridol (2.14), a synthetic flavone derived from the plant alkaloid rohitukine, which 
was isolated from Dysoxylum binectariferum, is currently in phase II clinical trials against 
a broad range of tumours. It was found to be the first anticancer agent that targets cell cycle 












The potential use of higher plants as sources of new drugs is still poorly explored. Of the 
estimated 250,000-500,000 plant species existing worldwide, only a small percentage has 
been investigated phytochemically, and a fraction submitted to biological or 
pharmacological screening is even smaller (Calixto et al. 2000).  
 
South Africa in particular, is blessed with a rich plant biodiversity of about 24 300 
indigenous plants (Mulholland and Drewes 2004), representing about 10% of the world’s 
13 
 
higher plants. Approximately 3000 plants are reported to be used medicinal and to have 
medicinal properties, but only a few have been described or studied (Coetzee et al. 1999; 
Taylor et al. 2001). 
 
The potential of using plants as anticancer agents was recognized in the 1950s by the U.S. 
National Cancer Institute (NCI) under the leadership of the late Dr. Jonathan Hartwell. The 
NCI, in its search for anticancer agents has tested 35,000 species of higher plants. Many of 
these have shown reproducible anticancer effects, and the active principles have been 
extracted from most of these and their structures determined. However, Cragg and 
Newman (2005) indicated that no new plant-derived clinical anticancer agents except 
Taxol (Christopher 1993) have, as yet, reached the stage of general use, but a number of 
agents are in preclinical development. 
 
 
2.4 Classes of plant-derived anticancer agents 
 
Kintzios (2006) classified plant-derived natural products with antitumour properties into 
thirteen distinct chemical groups. Of these, alkaloids, phenylpropanoids and terpenoids 
were found to be the best documented for their tumour cytotoxicity. Only the triterpenoids, 
sesquiterpene lactones, flavonoids and coumarins will be discussed, since these classes 





Triterpenoids are terpenoid-type compounds made from six isoprene units. These are 
naturally-occurring compounds with a C30 skeleton and are present as secondary 
metabolites in plants (Harborne and Baxter 1993). Examples are ursolic acid (2.15), 









































2.15 Ursolic acid  2.16 Oleanolic acid  2.17 Betulinic acid 
 
 
2.4.2 Sesquiterpene lactones 
 
Sesquiterpene lactones are a class of natural sesquiterpenoids, which are chemically 
distinct from other members of the group through the presence of a γ-lactone system. This 
class of compounds are biologically very active and are classified into four major groups: 
germacranolides with a 10-membered ring (Harborne and Baxter 1993), e.g., alatolide 
(2.18); eudesmanolides with two fused six-membered rings, e.g., alantolactone (2.19); 
guaianolides with a five-membered ring fused to a seven and a methyl substituent at C-4, 
e.g., archangelolide (2.20); and pseudoguaianolides, as guaianolides but a methyl 
substituent at C-5, e.g., ambrosin (2.21). 
 
Sesquiterpene lactones form one of the largest groups of cytotoxic and antitumour 
compounds of plant origin. Most of these active sesquiterpene lactones are found in species 
of the Asteraceae, although some of them originate in Magnoliaceae, Apiaceae and even 
fungi. A wide variety of sesquiterpene lactones isolated from plant extracts have 
demonstrated other pharmacological activities which include expectorant, blood pressure 
lowering, cholinergic, hypoglycaemic, anti-asthmatic and anti-inflammatory activity 







































































Flavonoids are compounds that are responsible for the colour of flowers, fruits and 
sometimes leaves. Flavonoids protect the plant from UV-damaging effects and play a role 
in pollination by attracting insects or birds by their colours. Their basic structure is 2-
phenyl chromane or Ar-C3-Ar skeleton (Harborne and Baxter 1993). Flavonoids are 
categorized as flavones, flavanones, flavonols, dihydroflavonols, flavan-3-ols, flavan-3,4-
diols and flavans. The best known flavonoids are the flavanones, e.g., naringenin (2.22); 


















Coumarins are shikimate-derived, benzo-α-pyrone derivatives that are present in plants 
both in a free state and as glycosides. Most natural coumarins contain a hydroxyl group at 
the C-7 position. Some coumarins are phytoalexins and are manufactured by the plant in 
the event of an infection by bacteria and fungi. Scopoletin is among such compounds 
(Harborne and Baxter 1993). 
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There are three major classes: the hydroxycoumarins, such as umbelliferone (2.24), the 











                                            





Cancer is a human tragedy that strikes and kills the lives of our beloved people. With 
limited number of effective anticancer drugs from natural resources currently in use, there 
is a real need for new, safe, cheap and effective anticancer drugs to combat this dreaded 
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Materials and Methods 
 
3.1 Plant collection 
 
Two basic methods of plant collections were employed in this study, the random method 
and ethnobotanical method. In the random method, plants were randomly selected based on 
what was available and what could be identified. The ethnobotanical method relied on the 
knowledge of local, indigenous people (in this case, traditional healers). Plants were 
collected by two botanists, Hans Vahrmeijer and Jean Meyer. Voucher specimens were 




3.2 Processing and extraction of plant material 
 
The collected plant materials were oven-dried at 30-60 ºC and the drying time and 
temperature varied depending on the nature of the plant part. The dried plant materials 
were milled to a coarse powder and stored at ambient temperature prior to extraction. 
 
The dried and ground plant materials were extracted with methanol/dichloromethane (1:1) 
for a period of 1-2 days at room temperature. The solvent was evaporated using a rotary 
evaporator at 50-60 ºC and then further dried either in a dessicator for 24 h or in a fume 
hood for 5 days. The extracts were stored in a cold room at -20 ºC until used. 
 
 
3.3 Liquid-liquid partitioning of extracts 
 
A liquid-liquid partitioning step was employed to separate the extracts based on polarities. 
The organic extract was first dissolved in methanol/water (9:1) and then partitioned with 
hexane three times using a separatory funnel. The combined hexane layers and the 
methanol from the methanol/water layer were evaporated under reduced pressure. 
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Additional water was added to the remaining water layer and further partitioned, three 
times with dichloromethane. The combined dichloromethane layers were concentrated, 





3.4.1 Column Chromatography 
 
Different sized columns, ranging from 1.5-8 cm in diameter, were used depending on the 
amount of sample available and the purification stage. Separation of crude extracts was 
generally carried out on a column using silica gel 60 (0.063-0.2 mm). Flash column 
chromatography was carried out using 35-75 micron flash silica gel (Merck). All 
separations were carried out under gravity. 
 
 
3.4.2 Thin-layer chromatography 
 
Thin-layer chromatography was carried out on pre-coated glass plates (Merck, SIL G-25 
UV254, 20 cm x 20 cm). The plates were first viewed under ultraviolet (UV) light 
(shortwave 254 nm and long wave 366 nm) and then sprayed with a vanillin- H2SO4 (1 g 




3.4.3 Preparative thin-layer chromatography 
 
Compounds which were visible under UV light were isolated using this technique. The 
glass plates were lined with the sample, 1.5 cm from the bottom of the plate. The samples 
were loaded onto the plates by using a Pasteur pipette containing the sample from one end 
of the plate to the other end. The plates were then developed in a chromatography tank and 
the compounds of interest were detected under UV light. The bands were then removed, 
dissolved in methanol and dichloromethane and then filtered to remove the silica gel from 
the filtrate containing compounds of interest. 
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3.4.4 Vacuum Liquid Chromatography 
 
This technique was used to fractionate crude extracts. A sintered glass funnel was used, dry 
packed with a suitable adsorbent such as silica gel of TLC grade. The packing was done 
under vacuum to achieve maximum packing density. The solvent was poured and sucked 
dry under vacuum. The sample was loaded in the form of dry slurry and vacuum reapplied 
to settle the sample. A small amount of silica gel was added on it and filter paper (round, of 
sintered funnel circumference) was placed on it. Then the column was eluted with 
appropriate solvent mixture (or solvent of increasing polarity). In each attempt the column 
was sucked to dryness. 
 
 
3.4.5 Gas chromatography-Mass Spectrometry (GC-MS) 
 
GC-MS analyses were carried out on an Agilent 7890A GC instrument coupled to a 5975C 
inert Mass Selection Detector (MSD) system provided with an HP-5MS capillary column. 
GC-MS analysis conditions: Injection temperature: 250 
o
C; mode: pulsed splitless; 
detector temperature: 300 
o
C; capillary column: 30 m, 0.32 mm, 0.25 μm film thickness. 
The temperature program was as follows: from 45 
o
C (1 min) to 280 
o
C (0 min) at 25 
o
C 
/min then to 320 
o
C (1 min) at 5 
o
C/min. The injection volume was 1 μl. Helium was used 
as a carrier gas at a flow rate of 1.2 ml/min. MS was in EI mode at 70 eV. 
The identification of the compounds in the chromatographic profiles was achieved by 





3.5.1 Nuclear Magnetic Resonance (NMR Spectroscopy) 
 
NMR spectroscopy was carried out on either a 400 MHz Varian Unity Inova spectrometer 
or on Bruker Avance III 400 or 500 MHz spectrometers at the CSIR and University of 
KwaZulu-Natal, respectively. All spectra were recorded at room temperature in either 
deuterated chloroform, deuterated methanol, a mixture of deuterated chloroform and 
methanol or deuterated dimethylsulphoxide. The chemical shifts were all reported in ppm 
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relative to tetramethylsilane (TMS). Structural characterizations were carried out using a 








3.5.2 Mass Spectrometry (MS) 
 
Mass spectra were obtained from a coupled HPLC-UV/MS instrument with a triple pole 
Quattro LC Micro mass spectrometer or on a Waters LCT Premier operating in the ESI 
positive or ESI negative modes at the CSIR and University of KwaZulu-Natal respectively. 
High-resolution mass spectroscopy was performed at the University of Witwatersrand, 
South Africa on a VG 70SEQ MS instrument, operated at 8 kV in the positive EI mode. 
 
 
3.6 Physical constants 
 
3.6.1 Optical Rotation 
 
Optical rotations were recorded at room temperature on a Perkin Elmer 241 Polarimeter at 
589 nm using a sodium lamp as a light source and a 1 dm cell. 
 
 
3.6.2 Melting points 
 
Melting points for crystalline compounds isolated were determined using a Reichert hot 
stage apparatus and are uncorrected. 
 
 
3.7 Biological assays 
 
3.7.1 In vitro anticancer assay 
 
Anticancer assays were performed at the CSIR, South Africa and also at the National 
Cancer Institute (NCI) in the United States of America, in accordance with the protocol of 
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the Drug Evaluation Branch, National Cancer Institute (Monks et al. 1991; Kou et al. 1993; 
Leteurtre et al. 1994). Extracts and compounds were assayed in the 3-cell line panel 
consisting of TK10 (renal), MCF7 (breast), and UACC62 (melanoma). The extracts or 
compounds were tested at a single concentration (100 μg/ml) and the culture was incubated 
for 48 hrs. 
 
End point determinations were made with a protein-binding dye, sulforhodamine B (SRB). 
The growth percentage was evaluated spectrophotometrically versus controls not treated 
with test agents. Results for each extract/compound were reported as the growth 
percentage of the treated cells, compared to that of the untreated control cells. Extracts and 
compounds which reduced the growth of two of the cell lines by 75% or more, were 
further tested at five serial dilution concentrations ranging from 6.25 - 100 μg/ml for 
extracts or 10 fold dilutions for compounds. 
 
The results of the five-dose assays were reported as total growth inhibition (TGI). The 
assay results for the extracts screened were separated into four categories: inactive (TGI > 
50 μg/ml), weak (15 μg/ml < TGI < 50 μg/ml), moderate (6.25 μg/ml < TGI < 15 μg/ml) 
and potent (TGI < 6.25 μg/ml). 
 
Extracts from the latter two categories were selected for further in vitro testing for selective 
cytotoxicity against panels of human cancer cell lines at the NCI. The NCI panel of 60 cell 
lines included leukemia (L) lines, non-small cell lung cancer (NSCLC) lines, colon cancer 
(CL) lines, central nervous system cancer (CNSC) lines, melanoma (M) lines, ovarian 
cancer (OC) lines, renal cancer (RC) lines, prostate cancer (PC) lines and breast cancer 
(BC) lines. 
 
The results from NCI were reported as mean log10 functions of the three response 
parameters, GI50 (50% growth inhibition), TGI (drug concentration that is indicative of the 
cytostatic effect of the test agent) and LC50 (50% lethal concentration indicative of the 
cytotoxic effect of the test agent), calculated for each cell line. The in vitro results were 
classified as follows: 
log GI50 >1.10 to 1.5, the extract was considered weakly active 
log GI50 > 0 to 1.0, the extract was considered moderately active 
log GI50 < 0, the extract was considered potent 
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3.7.2 In vitro antiplasmodial assay 
 
This assay was carried out at the Department of Pharmacology, University of Cape Town. 
Samples were prepared as a 2 mg/ml stock solution in 10% DMSO or 10% methanol and 
were sonicated to enhance solubility. Stock solutions were stored at -20 ºC. The test 
samples were tested in duplicate against a chloroquine sensitive (D10) strain of 
Plasmodium falciparum. Continuous in vitro cultures of asexual erythrocytes stages of P. 
falciparum were maintained using a modified method of Trager and Jensen (1976). 
Quantitative assessment of antiplasmodial activity in vitro was determined via the parasite 
lactate dehydrogenase (pLDH) assay using a modified method described by Makler (1993).  
Chloroquine (CQ) was used as the reference drug in all experiments. A full dose-response 
was performed for all samples to determine the concentration inhibiting 50% of parasite 
growth (IC50 value). Test samples were tested at a starting concentration of 100 μg/ml, 
which was then serially diluted 2-fold in complete medium to give 10 concentrations, with 
the lowest concentration being 0.2 μg/ml. CQ was tested at a starting concentration of 100 
ng/ml. The highest concentration of solvent to which the parasites were exposed to had no 
measurable effect on the parasite viability. 
 
Dose-response curves were constructed using non-linear dose-response curve fitting 
analyses with GraphPad Prism v.4.0 software. The concentration of the drug that inhibits 




3.7.3 In vitro Cytotoxicity Assay 
 
Cytotoxicity assays were conducted by the Department of Pharmacology, University of 
Cape Town (UCT). This assay was performed on Chinese Hamster Ovarian (CHO) cells 
using the 3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyltetrazolium bromide (MTT) 
calorimetric assay. The MTT assay is used as a colorimetric assay for cellular growth and 
survival and compares well with other available assays (Mosmann 1983; Rubinstein et al. 
1990). The tetrazolium salt MTT was used to measure all growth and chemosensitivity. 
The test samples were tested in triplicate on one occasion. 
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Samples were dissolved in methanol/water (1:9). Stock solution (2 mg/ml) was prepared 
and stored at -20 ºC until use. The highest concentration of methanol to which the cells 
were exposed to had no measurable effect on the cell viability. Emetine was used as the 
positive control in all cases. The initial concentration of emetine was 100 µg/ml, which 
was serially diluted in complete medium with 10-fold dilutions to give 6 concentrations, 
the lowest being 0.001 µg/ml. The same dilution technique was applied to all test samples 
with an initial concentration of 100 µg/ml to give 5 concentrations, with the lowest 
concentration being 0.010 µg/ml. In the initial stage of the experiments, the cells were 
adjusted to a concentration of 10
5
/ml and 100 µl of this cell suspension were seeded in all 
wells except in column 1 (blank) in a 96-well culture plate (costar). The plates were 
incubated at 37 ºC for 24 h in a humidified 5% CO2 – air atmosphere. After the incubation 
period, the medium was carefully aspirated out of the wells and 100 µl of the different test 
substances (drug solutions) were added in quadruplicate to columns 3 through to 9. A 
further 100 µl of culture medium was then added to all of the wells containing cells and 
drugs (columns 3 to 9), and 200 µl of medium was dispensed to the wells in column 1 
(blank) and column 2 (cells and no drug). The microplate was then incubated at 37 ºC for 
48 h.  
After the 48 h incubation period, 25 µl of sterile MTT (5 mg/ml in PBS) was added to each 
well and incubation was continued for 4 h at 37 ºC. The plates were then centrifuged at 
2050 rpm for 10 minutes and the supernatant was carefully aspirated from the wells, 
ensuring that the formazan crystals were not disturbed. The formazan crystals were 
dissolved in DMSO (100 µl) and the plate was gently shaken for 5 min on a microtitre 
plate shaker. The plate was blanked on the wells in column 1 and the absorbance of the 
crystals was measured at λ 540 nm on a microtitre plate reader (Cambridge Technologies). 
The cell viability was calculated in each well using the formula: 
 
% cell viability = 
Aλ540 test well (cells + drug) X 100 
Aλ540 control well (cells + no drug) 
 
The concentration of drug that inhibits 50% of the cells (IC50 values) for these samples 
were obtained from dose-response curves, using a non-linear dose-response curve fitting 
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Bioassay-guided isolation of cytotoxic components from Anthospermum 




4.1.1 Review of Anthospermeae 
 
The tribe Anthospermeae belongs to the huge, mostly woody, tropical and subtropical 
family Rubiaceae, one of the largest of all angiosperm families, with about 637 genera and 
more than 10 000 species (Bremer et al. 1995; Bremer et al. 1999; Mongrand et al. 2005; 
Natali et al. 1995). Anthospermeae and Theligoneae are the only tribes in the family 
Rubiaceae which are comprised of wind-pollinated taxa (Puff 1986a). 
 
According to Kirkbribe (1982), Anthospermeae is one of the most advanced tribes in the 
family, with foliaceus stipules, herbaceous habitat and fleshy fruits. This tribe is widely 
distributed and occurs in tropical, subtropical and temperate regions of the southern 
hemisphere. It consists of approximately a dozen genera and comprises several hundred 
species and is believed to be closely related to the tribe Paederieae (Puff 1982; Puff 
1986a). 
 
The subtribe, Anthosperminae is restricted to Africa, Arabia in the Yemen Arab Republic, 
Madagascar, the Canary Islands and Madeira and is characterized by dry, dehiscent fruits 
with the exception of dry, indehiscent fruits in a few Nenax species, and unisexual and /or 
protandrous hermaphrodite flowers (Puff 1982; Puff 1986a). Anthosperminae comprises of 
five genera, Anthospermum, Galopina, Nenax, Carpacoce and Phyllis.  
 
Anthospermum L., the largest genus with thirty-nine species, is widely distributed in Africa 
south of the Sahara and in Madagascar. The highest concentration of taxa is found in 
Southern Africa; 21 species (29 taxa) occur in this flora area, of which 18 spp. (26 taxa) 
are endemic; of these, 10 spp. (16 taxa) are endemic to the south-western Cape region 
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(map, Fig. 4.1). This genus comprises large to medium-sized shrubs, dwarf shrubs, short-




Figure 4.1: Geographical distribution of Anthospermum in Southern Africa (Puff 1986a) 
 
 
4.1.2 Background on Anthospermum hispidulum E.Mey. ex Sond. 
 
Anthospermum hispidulum (Fig. 4.2) is a dwarf shrub with often thick, woody roots, non-
dioecious hairy species with large funnel shaped male and female flowers, long corolla 
tubes, and small, narrow fruits. The leaves are arranged decussately and the stems are 
about 15-40 cm long. A. hispidulum is believed to be closely allied to A. whyteanum and is 
found growing on rocky ridges, in cracks of rocky sheets, on rocky outcrops in grassland, 
on koppies, on rock ledges or krantzes, or amongst boulders, less commonly in rocky 





Figure 4.2: Anthospermum hispidulum 
 
 
The distribution of A. hispidulum (Fig. 4.3) is limited to only four provinces in South 
Africa (Limpopo, KwaZulu-Natal, Eastern Cape and Free State) and Swaziland (Puff 










To our knowledge, there is no published ethnopharmacology information on A. hispidulum, 
but other species of the genus Anthospermum have long been used in folk medicine to treat 
various ailments.  A decoction of A. rigidum is used by the Tswana and Kwena people to 
relieve toothache. The roots of A. pumilum are used as a remedy for painful menstruation 
and also during pregnancy. A. hedyotideum and A. rigidum are both used as charms to 
hasten convalences and also for various other protective purposes (Hutchings et al. 1996; 







4.2 Phytochemical studies 
 
From a phytochemical point of view, no previously reported investigations were found for 
A. hispidulum. Moreover, only a few species of the genus Anthospermum have been 
investigated for their chemical constituents. The flavonoids quercetin 7-O-glucoside (4.1), 
quercetin 3-O-glucoside (4.2) and kaempferol 3-O-glucoside (4.3), were isolated from the 
leaves of A. littoreum, A. galpinii, A. aethiopicum, A. usambarense and A. emirnense. 
Iridoid glycosides, e.g. asperuloside (4.4), were isolated from A. aethiopicum (Harborne 















































4.3      4.4 
 
 
4.3 Isolation of active compounds 
 
Leaves of A. hispidulum collected from Steenkampsberg near Lydenberg, Limpopo 
province in South Africa were dried, ground and extracted with methanol/dichloromethane 
(1:1) for 24 hours at room temperature (Fig. 4.4). The organic crude extract was assayed 
and found to have moderate anticancer activity (Chapter 3) against a panel of three human 
cancer cell lines at CSIR and weak activity (Chapter 3) against a panel of sixty human 
cancer cell lines at the NCI. This extract was subjected to liquid-liquid partitioning 
between hexane, methanol/water and dichloromethane. This led to three fractions i.e. a 
34 
 
hexane, dichloromethane and aqueous fraction. Of these, only the dichloromethane fraction 
retained activity in the CSIR screen. 
 
The dried dichloromethane extract was fractionated by column chromatography using 
silica gel as the stationary phase and different solvent mixtures (hexane, dichloromethane, 
acetone and methanol) of increasing polarity as the mobile phase. Seven fractions were 
obtained and repeated flash chromatography of these fractions led to the isolation of three 













            


































1. Partition between MeOH/H2O and hexane, separate 
2. Evaporate MeOH & hexane 




Repeated flash chromatography 
1. Extract with MeOH/CH2Cl2 
2. Filter, evaporate 
 
Fractionation using silica gel 
5%MeOH/CH2Cl2 
Fractionation using silica gel 
5%MeOH/CH2Cl2 
Hexane extract 




(Moderate anticancer activity) 
Fraction 4A-C 
(Weak anticancer activity) 
 
Fraction 5A-D 
(Weak anticancer activity) 
Fraction 5E-J 
(Moderate anticancer activity) 
 
Fraction 5K-M 
(Weak anticancer activity) 
Fraction 4D 
(Moderate anticancer activity) 
Fraction 4E-G 
(Weak anticancer activity) 
Organic extract 
(Moderate anticancer activity) 




Ursolic acid  
(moderate activity) 
 
Figure 4.4: Flow diagram illustrating the purification of the organic extract 
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4.3.1 Structural elucidation of scopoletin (4.5) 
 
Compound 4.5 was isolated as yellow crystals. The high resolution EI mass spectrum gave 
a molecular ion signal [M]
+ 
at m/z 192.04358, corresponding to a molecular formula of 
C10H8O4 and a distinct fragment peak at m/z 121.02964 due to [M-C3H3O2]
+ 
 (Fig. 4.5) 
 
 SCAN GRAPH. Flagging=High Resolution M/z. Highlighting=Base Peak. 
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H NMR spectrum (Plate 1) showed a pair of doublets at δH 6.22 and δH 7.55 (each 
1H, d, J 9.5 Hz), assigned to H-3 and H-4 of an α-pyrone ring system. It also showed the 
presence of two aromatic proton singlets in the region δH 6.80 – 6.88 and methoxyl protons 
at δH 3.91. The
 13
C NMR spectrum (Plate 2) showed nine sp
2
 carbon signals, which were 
assigned by using the DEPT spectrum (Plate 3) as four CH carbons and five quaternary 
carbons including an ester carbonyl at δC 161.5 and three oxygenated carbons at δC 144.2, 
149.9 and 150.5. 
 
Compound 4.5 was identified as 7-hydroxy-6-methoxycoumarin, also known as scopoletin. 











Carbon type  δC δH 







δH (J in Hz) 
2 -C=O 161.5  H-4 160.9  
3 -CH 113.6 6.22 d (9.5)  113.3 6.20 d (9.5) 
4 -CH 143.4 7.55 d (9.5) H-5 144.6 7.85 d (9.5) 
4a -C 107.7  H-8, H-3 109.7  
5 -CH 111.7 6.80 s H-4 112.0 6.84 s 
6 -C 149.9  H-8 151.9  
7 -C-OH 144.2  H-5 145.6  
8 -CH 103.4 6.88 s  103.7 6.59 s 
8a -C 150.5  H-5, H-4 151.8  
OCH3 -CH3 56.6 3.91 s  56.7 3.86 s 
















4.3.2 Structural elucidation of ursolic acid (4.6) 
 
Compound 4.6 was isolated as white crystals. The FAB mass spectrum of compound 4.6 
showed a molecular ion signal [M]
+ 
at m/z 456.0 which corresponds to the molecular 




 and 393 [M-
CH3O3]
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H NMR spectrum (Plate 6) showed that compound 4.6 has five three-proton singlets 
indicating tertiary methyls at δH 0.70, 0.74, 0.84, 0.90 and 1.01 and two doublets of  
secondary methyls at δH 0.78 (3H, d, J 6.5 Hz) and 0.86 (3H, d, J 6.1 Hz). It further 
showed an olefinic proton at δH 5.16 (1H, t, J 3.5 Hz, H-12), a proton doublet at δH 2.11 
(1H, d, J 11.8 Hz, H-18) and a doublet of doublets at δH 3.11(1H, dd, J 9.0, 7.0 Hz, H-3). 




C NMR spectrum (Plate 7) showed the presence of 30 carbon signals: a carboxylic 
acid at δC 180.8, olefinic carbons at δC 125.8 and 138.5, an oxygenated carbon at δC 79.0, 
and seven methyls at δC 15.6, 15.8, 17.1, 17.2, 21.3, 23.7 and 28.3. Therefore, the structure 
of 4.6 was assigned as ursolic acid. MS and
 13
C NMR spectral data of compound 4.6 are in 
agreement with those reported in the literature (Thanakijcharoenpath and Theanphong 

























δH (J in Hz) 
 
1 38.9  38.2  
2 27.1  27.0  
3 79.0 3.11(1H, dd, J =9.0, 7.0) 76.8 2.99 (1H, dd, J =10.5, 
5.2) 
4 39.0  38.5  
5 55.6  54.8  
6 18.6  18.0  
7 33.4  32.7  
8 39.8  39.1  
9 47.9  47.0  
10 37.2  36.5  
11 23.6  22.8  
12 125.8 5.16 (1H, t, J = 3.5) 
 
124.6 5.12 (1H, br t, J = 3.4) 
13 138.5  138.2  
14 42.4  41.6  
15 29.9  27.5  
16 24.5  23.8  
17 48.1  46.8  
18 53.2 2.11 (1H, d, J = 11.8) 52.4 2.10 (1H, d, J = 11.6) 
19 39.4  38.5  
20 39.2  38.4  
21 30.9  30.2  
22 37.1  36.3  
23 28.3 0.90 (3H, s) 28.2 0.88 (3H, s) 
24 15.6 0.74 (3H, s) 16.1 0.67 (3H, s) 
25 15.8 0.70 (3H, s) 15.2 0.86 (3H, s) 
26 17.2 0.84 (3H, s) 16.9 0.74 (3H, s) 
27 23.7 1.01 (3H, s) 23.3 1.03 (3H, s) 
28 180.8  178.3  
29 17.1 0.86 (3H, d, J = 6.1) 17.0 0.80 (3H, d, J = 6.4) 
30 21.3 0.78 (3H, d, J = 6.5) 21.0 0.89 (3H, d, J = 8.9) 
*- Thanakijcharoenpath and Theanphong 2007 
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4.4 Biological activity of the crude extract and isolated compounds 
 
4.4.1 In-vitro anticancer activity 
 
Anticancer assays were performed at both CSIR and the NCI. A. hispidulum was identified 
through random screening at the CSIR and the dichloromethane/methanol extract exhibited 
moderate anticancer activity when tested against a panel of three human cancer cell lines at 
the CSIR (Fig. 4.7; TGI value of between 12.5 and 25 µg/ml), while weak anticancer 
activity (Fig. 4.10; average log GI50 of 1.41) against 60 human cancer cell lines was 
observed at the NCI. Bioassay-guided fractionation of the crude extract was conducted and 
led to the isolation of two compounds. Compounds 4.5 and 4.6 were evaluated for 
anticancer activity at the CSIR. Ursolic acid (4.6) showed a significant improvement in 
activity (Fig. 4.9; TGI value between 6.25 and 12.5 µg/ml), while scopoletin (4.5) did not 
show any significant activity in all three cell lines (Fig. 4.8). Therefore, ursolic acid (4.6) 
can be considered as an active ingredient since its activity compares well to that of the 
crude extract.  
 
The results from CSIR are presented as dose-response curves for each sub-panel 
(melanoma, breast and renal). The dose response curve is a plot of percent growth (PG) 
against the concentration for each cell line. The response parameters GI50 (50% growth 
inhibition), TGI (total growth inhibition) and LC50 (lethal concentration killing 50% of 
cells) are interpolated values from these graphs representing the concentrations at which 
PG is +50, 0 and -50 respectively 
40 
 
The results from NCI were reported as mean log10 functions of the three response 
parameters, GI50 (50% growth inhibition), TGI (drug concentration that is indicative of the 
cytostatic effect of the test agent) and LC50 (50% lethal concentration indicative of the 
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Figure 4.10: Mean log10 functions of the three response parameters, GI50, TGI and LC50 of 





Bioassay-guided fractionation of the organic extract of A. hispidulum resulted in the 
isolation of scopoletin (4.5) and ursolic acid (4.6). Ursolic acid (4.6) exhibited moderate 
anticancer activity and it is most likely that the activity observed in the crude extract can be 
attributed to ursolic acid (4.6). 
 
Literature searches indicated that ursolic acid (4.6) and its derivatives have been patented 
for their anticancer properties by Japanese scientists (Ishida et al. 1990). Ursolic acid (4.6) 
has also been reported to possess a wide range of pharmacological activities, including 
anti-HIV, anti-inflammatory, antitumor, hepatoprotective, anti-ulcer, antimicrobial and 
anti-hyperlipidemic (Liu 1995; Kashiwada et al. 2000; Dzubak et al. 2006). 
 
Scopoletin (4.5) did not show any activity in all three cell lines. However, it has been 
reported to possess many biological activities, including anti-inflammatory effect 
(Muschietti et al. 2001), inhibition of monoamine oxidase (Yun et al. 2001) and inducible 
nitric oxide synthase (Kang et al. 1999; Kim et al. 1999), hepatoprotective effects (Kang et 
al. 1998), antibacterial (Kayser and Kolodziej 1997) and antioxidant activity (Shaw et al. 
2003) and cytotoxicity (Moon et al. 2007). 
Compounds isolated here are known compounds, but have not been previously reported as 















4.6.2 Plant Material 
 
The leaves of the plant were collected in April 2004 from Steenkampsberg near 
Lydenberg, Limpopo province in South Africa. The plant was identified by the South 
African National Biodiversity Institute (SANBI) in Pretoria as Anthospermum hispidulum 
E.Mey. ex Sond. (Genspec number 8438000 32) and a voucher specimen was deposited in 
the herbarium of SANBI. The leaves (6.5 kg) were oven dried at 50 
o
C overnight and 
milled to a coarse powder. 
 
 
4.6.3 Extraction and Isolation 
 
The dried and ground leaves of Anthospermum hispidulum (4.9 kg) were extracted with 
methanol/dichloromethane (1:1) for 24 h at room temperature, after which the solvent was 
evaporated using a rotary vacuum evaporator at 50 
o
C and then further dried in a desiccator 
for 24 h. The resulting extract (106.7 g) was dissolved in methanol/water (9:1) and then 
partitioned between hexane, dichloromethane and water/methanol (Fig. 4.4). The 
dichloromethane residue (30 g) was fractionated by vacuum liquid chromatography (VLC) 
on silica gel in a stepwise fashion using solvent mixtures of increasing polarity from 
hexane to dichloromethane, ethyl acetate, acetone and methanol. Seven fractions (labelled 
fraction 4A-G) were obtained and then further fractionated using flash chromatography as 
follows: Fraction 4D (5.5 g) was fractionated by flash chromatography using 5% 
methanol/dichloromethane as eluant, resulting into 13 sub-fractions (fraction 5A-M). 
Repeated flash chromatography of sub-fractions 5E-J (1.3 g) using 5% 
methanol/dichloromethane as eluant led to the isolation of compound 4.6 (25 mg). 
 
Sub-fractions 5K, L and M (2.1 g) were combined and further subjected to flash 
chromatography employing acetone/chloroform (1:9) as eluant to yield a fluorescing blue 









4.6.4 Physical data 
 
4.6.4.1 Physical data for scopoletin (4.5) 
 
Physical description: yellow crystals 
Molecular formula: C10H8O4 
Yield: 8.5 mg 
UV maxima: 203.0, 227.6 and 343.4 nm 





C (Kayser and Kolodziej 1995)] 
1
H NMR: Plate 1 
13
C NMR: Plate 2 
DEPT: Plate 3 
HSQC: Plate 4 
HMBC: Plate 5 
 
 
4.6.4.2 Physical data for ursolic acid (4.6) 
 
Physical description: white crystals 
Molecular formula: C30H48O3 
Yield: 25 mg 
FABMS m/z: 456 




C (Thanakijcharoenpath and Theanphong 2007)] 
Optical rotation: [α]D +61.0, c = 0.054, MeOH/CHCl3 [lit. [α]D +67.5, c = 1.0, KOH 
(Budavari et al. 1989) 
1
H NMR: Plate 6
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5.1.1 Review of the genus Eriocephalus L. 
 
The genus Eriocephalus L., commonly known as ‘wild rosemary’, ‘Cape snow bush’, 
‘kapokbos’ or ‘asmabossie’ belongs to the largest flowering plant family Asteraceae, 
which has about 1535 genera and 25000 species worldwide. This family is found in 
abundance on every continent except Antarctica. It is most concentrated in Southern Africa 
(Botswana, Lesotho, Namibia and South Africa). In South Africa, there are about 250 
genera and 2300 species of Asteraceae. Eriocephalus L., is considered to be a distinct 
genus in the tribe Anthemideae, whose species are characterized by an aromatic scent and 
dissected leaves (Bremer and Humphries 1993; Muller et al. 2001; Njenga et al. 2005; 
Njenga 2005; Viljoen at al. 2006; Germishuizen et al. 2007). 
 
The genus Eriocephalus comprises thirty-two species (total of 42 taxa), all endemic to 
Southern Africa. Its name is derived from the Greek words erion cephalus meaning wool 
headed. Its distribution covers the whole of the Flora of Southern Africa (FSA) region 
except Gauteng and KwaZulu-Natal provinces, with the highest concentration of taxa in 
the Western and Northern Cape provinces (Muller et al. 2001; Njenga 2005). 
 
Eriocephalus species occur in a variety of habitats ranging from coastal (Fig. 5.1) to inland 
on plains, mountains and the desert. Morphologically, members of the genus are many-
stemmed, sparsely to much-branched, erect to spreading, sometimes spinescent shrubs, 
rarely suffrutices, and 0.2-2.0 m high and in diameter and are often aromatic. With the 
exception of E. pinnatus and E. longifolius, members of Eriocephalus display anomalous 
secondary growth, resulting in the splitting of older plants into independent daughter plants 





Figure 5.1: Eriocephalus africanus showing a spreading habit in a rocky coastal habitat 
 
 
Eriocephalus L. is also characterized by the heterogeneous heads, the female ray florets 
with bifid style, mostly ligulate, the disc florets being tubular, five-toothed, and male with 
perfect stamens and simple, club shaped and truncate styles. Traditionally the genus is 
placed in the tribe Anthemideae, subtribe Anthemidinae. However, this genus in now 
grouped together with Brachylaena, Tarchonanthus and Osmitopsis in the Lasiospermum 
group with other South African genera (Zdero et al. 1987; Muller et al. 2001). 
 
 
5.1.2 Background on Eriocephalus tenuifolius DC. 
 
Eriocephalus tenuifolius DC. (Fig. 5.2), commonly known in Afrikaans as boegoekapok or 
klein-bergkapokbossie, is a rigid, erect, many-stemmed perennial shrub that reaches a 
height of 0.3-1.3 m. E. tenuifolius is closely related to E. punctulatus, and these species, 
can be separated by their leaf size, peduncle length, the length of the subtending leaves of 
the peduncles and their distribution. The other distinguishing character is the fact that E. 






Figure 5.2: Eriocephalus tenuifolius 
 
The distribution of E. tenuifolius (Fig. 5.3) is restricted to five provinces in South Africa 
(Mpumalanga, Free State, Eastern Cape, Western Cape and Northern Cape) and Lesotho. 
 
 






Several species of Eriocephalus L. are economically important as traditional herbal 
remedies and as perfumes in fragrance industries. E. africanus, a fragrant herb, has been 
used to treat oedema, colds, coughs, gastrointestinal disorders, dermal infections, 
gynaecological conditions and is also used as a rosemary substitute for culinary flavouring 
purposes. It is also used in the treatment of stress related ailments and depression (Van 
Wyk and Gericke 2000; Njenga 2005; Njenga and Viljoen 2006; Merle et al. 2007). The 
Griqua and the Nama used E. ericoides, E. racemosus, E. africanus, E. punctulatus and E. 
umbellatus as diuretics and diaphoretics (Watt and Breyer-Brandwijk 1962; Van Wyk et al. 
1997). E. punctulatus is also used in the treatment of stomach diseases (Mierendorff et al. 
2003; Njenga and Viljoen 2006). The oils from E. punctulatus and E. africanus have a 
wide application in perfumes, skin care preparations and as blend oils in beauty care 
products (Njenga and Viljoen 2006). 
 
No special use is published concerning E. tenuifolius. Claims have been made by a 
traditional doctor, the late Solomon Mahlaba who brought the plant as a substitute for 
buchu (Muller et al. 2001), to CSIR. This study was prompted by this claim and because of 
the anticancer in-house screen at the CSIR, it was decided to test both the aqueous and 
organic extracts of E. tenuifolius for anticancer properties. Initial in vitro results of the 
organic extract against a panel of three human cancer cell lines at CSIR looked promising. 
 
 
5.2 Phytochemical studies 
 
Zdero et al. (1987) isolated camphor (5.1), linalyl acetate (5.2), nerolidol (5.3), squalene 
(5.4), flavonoids e.g. quercetin (5.5) and several sesquiterpene lactones: guaianolides e.g. 
estafiatin (5.6), eudesmanolides e.g. ivangustin (5.7), germacranolide e.g. parthenolide 
(5.8), derivatives of costic acid (5.9), a seco-eudesmane diketone (5.10) and a 
chrysanthemol derivative (5.11) from nine Namibian Eriocephalus species (E. africanus, 
E. ericoides, E. scariosus, E. ambigius, E. merxmullerii, E. pauperrimus, E. kingesii, E. 
giessii and Eriocephalus sp). 
The chemistry of other species is relatively unknown and undocumented. To our 
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5.3 Isolation of active compounds 
 
The aerial parts of E. tenuifolius collected from Free State province in South Africa was 
dried, ground and sequentially extracted with purified water and 
methanol/dichloromethane (1:1) (Fig. 5.4). Both aqueous and organic extracts were 
assayed and the organic extract was found to have moderate anticancer activity (Chapter 3) 
against a panel of three human cancer cell lines at CSIR. The organic extract was 
fractionated by column chromatography on silica gel using 2-5% 
methanol/dichloromethane. Ten fractions were obtained and repeated fractionation of these 
fractions led to the isolation of the active compound, 8-O-isobutanoylcumambrin B (5.12) 



























i) Extract with water (4 hr) and filter 
ii) Freeze dry solution and dry residual plants 
iii) Extract with 1:1 (v/v) MeOH/CH2Cl2 (48 hr) 
iv) Filter and evaporate 
Fractionation using silica gel                                                                           
2-5% MeOH/CH2Cl2 
Repeated Flash Chromatography and /or preparative TLC 
Dried and ground 
aerial parts of plant 
Organic extract 





























5.3.1 Structural elucidation of 8-O-isobutanoylcumambrin B 5.12 
 
Compound 5.12 was isolated as white crystals. The ESI
-
-TOF mass spectrum (Fig. 5.5) 




at m/z 333.1693, corresponding to a molecular 
formula C19H26O5.  
 
 
Figure 5.5: The ESI
-





H NMR spectrum (Plate 8, Table 5.1) of compound 5.12 showed two doublet signals 
at δH 6.19 (1H, d, J 3.5 Hz, H-13) and 5.50 (1H, d, J 3.1 Hz, H-13), a broad doublet signal 
at δH 1.81 (1H, br d, , J 16.7 Hz, H-9β), three doublet of a doublet signals at δH 2.31 (1H, 
dd, J 16.7, 5.6 Hz, H-9α), 2.80 (1H, dd, J 9.5, 8.6 Hz, H-5) and 4.03 (1H, dd, J 10.5, 9.5 
Hz, H-6), a broad doublet of a doublet at δH 2.25 (1H, br dd, J 15.5, 7.8 Hz, H-2), a doublet 
of a doublet of a doublet at δH 5.22 (1H, ddd, J 9.2, 5.5,1.5 Hz, H-8), a triplet of a triplet at 
δH 3.89 (1H, tt, J 9.4, 3.2), a broad triplet at δH 2.11 (1H, br t, J ~ 12.5 Hz, H-2), and two 




C NMR spectrum (Plate 9, Table 5.1) showed nineteen carbon signals, consisting of 
two carbonyl carbon signals at δC 169.4 (C-12) and 176.0 (C-1'), three oxygenated carbon 
signals at δC 73.1 (C-8), 73.7 (C-10) and 80.3 (C-6), four methyl carbon signals at δC 17.9, 
18.8, 18.9 and 33.7 and four olefinic carbon signal at δC 121.1, 125.5, 138.7 and 143.8. 
These spectral data suggested that compound 5.12 was a quaiane-type sesquiterpene 









Compound 5.12 was identified as 8-O-isobutanoylcumambrin B. The NMR data 




















δH (J in Hz) 
1 -CH 54.2 2.60 m 54.2  
2 -CH2 33.5 2.25 br dd (15.5, 7.8) 
2.11 br t (~12.5) 
33.6  
3 -CH 125.5 5.52 br s 125.7 5.47 t (1.5) 
4 -C 143.8  143.7  
5 -CH 54.5 2.80 dd (9.5, 8.6) 54.5  
6 -CH 80.3 4.03 dd (10.5, 9.5) 80.4 3.98 t (11) 
7 -CH 46.8 3.89 tt (9.4, 3.2) 46.9 3.85 m 
8 -CH 73.1 5.22 ddd (9.2, 5.5, 
1.5) 
73.2 5.16 m 
9α 
9β 
-CH2 38.8 2.31 dd (16.7, 5.6) 
1.81 br d (16.7) 
38.8 2.28 dd (16.0, 
6.0) 
10 -C 73.7  73.7  
11 -C 138.7  139.6  





121.1 6.19 d (3.5) 
5.50 d (3.1) 
121.1 6.13 d (3.0) 
14 -CH3 33.7 1.23 s 33.8 1.20 s 
15 -CH3 17.9 1.93 s 17.8 1.88 t (1.5) 
1' -C=O 176.0  176.0  
2' -CH 34.2 2.65 septet (7.0) 34.1 2.60 m 
3' -CH3 18.8, 18.9 1.25 d (6.9) 18.8, 18.9 1.21 d (7.0) 







































In the HMBC spectrum (Plate 11, Fig 5.6), the hydrogen signal at δH 1.23 (H-14) showed 
correlations with carbon signals at δC 38.8 (C-9) and 54.2 (C-1). The methyl proton at δH 
1.93 (H-15) correlated with carbon signals δC 125.5 (C-3) and 143.8 (C-4). Correlations 
were also observed between methyl proton at δH 1.25 (H-3') with carbonyl carbon signal at 
δC 176.0, between methylene protons at δH 6.19 (H-13) and carbon signals at δC 46.8 (C-7), 

















Figure 5.6: HMBC correlations of compound 5.12 
 
 
5.3.2 Structural elucidation of pectolinarigenin 5.13 
 
Compound 5.13 was isolated as yellow crystals. The ESI
- 
mass spectrum (Fig.5.7) showed 




at m/z 313.10, corresponding to a molecular formula 
C17H14O6. The peaks observed in the spectrum at m/z 283.04 and m/z 267.99 were due to 





Figure 5.7: The ESI
- 





H NMR spectrum (Plate 12, Table 5.2) of compound 5.13 showed two doublets of 
similar coupling constants at δH  7.11 (2H, d, J 8.9 Hz, H-3', H-5'), and 8.04 (2H, d, J 8.9 
Hz, H-2', H-6'). It further showed two singlets at δH 3.86 (3 H, s, 6-OMe) and 3.76 (3H, s, 





C NMR spectrum (Plate 13, Table 5.2) showed seventeen carbon signals, consisting 
of a carbonyl carbon signals at δC 182.1, six oxygenated carbon signals at δC 131.4, 152.4, 
152.7, 157.4, 162.3 and 163.3. Two peaks at δC 114.5 (C-3') and 128.3 (C-2') showing 
double intensities were also observed in the 
13





















H NMR spectral data for pectolinarigenin 5.13 in DMSO-d6. 
Carbon 
number 
Carbon type  δC δH 








δH (J in 
Hz) 
2 -C 163.3  163.2  
3 -CH 103.0 6.87 s 103.2 6.83 s 
4 -C=O 182.1  182.3  
5 -C-OH 152.7 13.04 s 152.6 13.01 s 
6 -C 131.4  131.5  
7 -C-OH 157.4  157.5  
8 -CH 94.3 6.62 s 94.5 6.59 s 
9 -C 152.4  152.9  
10 -C 104.1  104.3  
1' -C 122.8  123.0  
2' -CH 128.3 8.04 d (8.9) 128.4 7.99 d (9.0) 
3' -CH 114.5 7.11 d (8.9) 114.7 7.08 d (9.0) 
4' -C 162.3  162.5  
5' -CH 114.5 7.11 d (8.9) 114.7 7.08 d (9.0) 
6' -CH 128.3 8.04 d (8.9) 128.4 7.99 d (9.0) 
6-OCH3 -CH3 59.9 3.76 s 60.1 3.74 s 
4'-OCH3 -CH3 55.5 3.86 s 55.7 3.84 s 




















The HMBC spectrum (Plate 16, Fig. 5.8), showed correlations between the proton at δH 
3.86 (OCH3) with the carbon signal at δC 162.3 (C-4'), between the hydrogen signal at δH 
3.76 (OCH3) and the carbon signal at δC 131.4 (C-6), between the hydrogen signal at δH 
7.11 (H-5') with the carbon signal at δC 122.8 (C-1') and between the hydrogen signal at δH 
6.62 (H-8) and the carbon signals at δC 104.1 (C-10) and 131.4 (C-6). It further showed 





The correlations observed in the NOESY experiment (Plate 17, Fig. 5.8), between proton 
signal at δH 7.11 (H-5') and proton signal at δH 3.86 (OCH3) indicate that the methoxy 












Figure 5.8: HMBC (             ) and NOESY (            ) correlations of compound 5.13 
 
 
From the spectral evidence, the structure of compound 5.13 was determined to be 5,7-
dihydroxy-6,4-dimethoxyflavone (known as pectolinarigenin). The structure was also 




5.3.3 Structural elucidation of hispidulin 5.14 
 
Compound 5.14 was isolated as yellow crystals. The ESI
- 
mass spectrum (Fig. 5.9) showed 




at m/z 299.08, corresponding to a molecular formula 
C16H12O6. The mass spectrum showed a fragment at m/z 268.99, corresponding to the 






Figure 5.9: The ESI
- 





H NMR spectrum (Plate 18, Table 5.3) of compound 5.14 showed six signals, two 
doublets at δH  6.91 (2H, d, J 8.7 Hz, H-3', H-5') and 7.91 (2H, d, J 8.7 Hz, H-2', H-6'), four 




H NMR spectrum of compound 5.14 was similar to that of compound 5.13, except for 




C NMR spectrum (Plate 19, Table 5.3) showed sixteen carbon signals, with two 
peaks at δC 115.9 (C-3') and 128.4 (C-2') showing double intensities, a carbonyl carbon 
signal at δC 182.1, a methoxyl signal at δC 59.9 and six oxygenated carbon signals at δC 
















H NMR spectral data for hispidulin 5.14 in DMSO-d6. 
Carbon 
number 
Carbon type  δC δH 








δH (J in 
Hz) 
2 -C 163.8  163.8  
3 -CH 102.3 6.77 s 102.4 6.75 s 
4 -C=O 182.1  182.1  
5 -C-OH 152.7 13.06 s 152.8 13.05 s 
6 -C 131.3  131.4  
7 -C-OH 157.2  157.3  
8 -CH 94.2 6.59 s 94.2 6.57 s 
9 -C 152.4  152.4  
10 -C 104.0  104.0  
1' -C 121.2  121.2  
2' -CH 128.4 7.91 d (8.7) 128.4 7.90 d (8.8) 
3' -CH 115.9 6.91 d (8.7) 115.9 6.90 d (8.8) 
4' -C-OH 161.1  161.2  
5' -CH 115.9 6.91 d (8.7) 115.9 6.90 d (8.8) 
6' -CH 128.4 7.91 d (8.7) 128.4 7.90 d (8.8) 
6-OCH3 -CH3 59.9 3.74 s 59.9 3.73 s 
     
#


















Correlations between H-6' (δH 7.91) and both H-3 (δH 6.77) and H-5' (δH 6.91) were 
observed in the NOESY spectrum (Plate 23, Fig. 5.10). 
 
From the HMBC spectrum (Plate 22, Fig. 5.10), the methoxyl proton at δH 3.74 (OCH3) 
correlates with the carbon signal at δC 131.3 (C-6), hydrogen signal at δH 6.59 (H-8) with 
carbon signals at δC 131.3 (C-6) and 104.0 (C-10). These correlations suggested that the 
methoxyl group is positioned at C-6. 
The HMBC spectrum further showed correlations between hydrogen signal at δH 6.91 (H-















Figure 5.10: HMBC (             ) and NOESY (          ) correlations of compound 5.14 
 
 




C NMR spectral 
data of compound 5.14 are in agreement with those reported in the literature for hispidulin 
(Hase et al. 1995).  
 
 
5.3.4 Structural elucidation of friedelinol 5.15 
 
Compound 5.15 was isolated as white crystals. The GC/MS spectrum (Fig. 5.11) showed a 
molecular ion [M]
+
 peak at m/z 428.4, corresponding to the molecular formula C30H52O. 
The ions at m/z 413.4, 275.2, 205.2 and 69.1 were due to the loss of a methyl, C11H21, 
C16H30O and C25H43O groups respectively. The National Institute of Standards and 










H NMR spectrum (Plate 24) showed the presence of one doublet methyl signal at δH 
1.02 (3H, d, J 6.1 Hz, 23-Me) and seven methyl singlet methyl signals at δH 0.88 (3H, s, 
24-Me), 0.89 (3H, s, 25-Me), 0.94 (3H, s, 29-Me), 0.95 (3H, s, 26-Me), 0.97 (3H, s, 27-




C NMR spectrum (Plate 25, Table 5.4) showed the presence of thirty carbon signals. 
Eight methyl carbon signals at δC 35.0, 32.1, 31.8, 20.1, 18.6, 18.2, 16.4, and 11.6 were 
assigned for C-29, C-28, C-30, C-26, C-27, C-25, C-24 and C-23 respectively. One 
oxygenated carbon signal at δC 72.7 assigned for C-3 was also observed. The 
13
C NMR 
shifts were found to be identical with 
13
C NMR reported spectrum (Table 5.4) of 3β-















H NMR spectral data for compound 5.15 in CDCl3. 
Carbon 
number 
Carbon type  δC δH 








δH (J in Hz) 
1 -CH2 15.8  16.2  
2 -CH2 36.1  36.1  
3 -CH 72.7  71.6  
4 -CH 49.2  49.6  
5 -C 37.9  38.1  
6 -CH2 41.8  41.9  
7 -CH2 17.6  17.7  
8 -CH 53.2  53.3  
9 -C 37.1  37.2  
10 -CH 61.4  61.7  
11 -CH2 35.4  35.7  
12 -CH2 30.6  30.7  
13 -C 38.4  38.4  
14 -C 39.7  39.7  
15 -CH2 32.4  32.3  
16 -CH2 35.6  35.9  
17 -C 30.0  30.0  
18 -CH 42.9  42.9  
19 -CH2 35.2  35.4  
20 -C 28.2  28.2  
21 -CH2 32.8  32.9  
22 -CH2 39.3  39.3  
23 -CH3 11.6 1.02 s 12.1 1.02 s 
24 -CH3 16.4 0.89 s 16.6 1.10 s 
25 -CH3 18.2 0.88 s 18.4 0.89 s 
26 -CH3 20.1 0.95 s 20.1 0.99 s 
27 -CH3 18.6 0.97 s 18.7 1.02 s 
28 -CH3 32.1 1.18 s 32.1 1.16 s 
29 -CH3 35.0 0.94 s 35.0 0.97 s 
30 -CH3 31.8 1.03 s 31.9 1.0 2 s 
#































5.3.5 Structural elucidation of tetracosanoic acid 5.16 
 
Compound 5.16 was isolated as white crystals. The GC/MS spectrum (Fig. 5.12) showed a 
molecular ion [M]
+
 peak at m/z 368.4, corresponding to the molecular formula C24H48O2.  
The mass spectrum showed various peaks having the difference of 28 a.m.u. (i.e. loss of 2 
x CH2) revealing the hydrocarbon nature of compound 5.16. The NIST library search 
confirmed a 99% match with tetracosanoic acid. 
 
 




H NMR spectrum (Plate 26) showed only four signals, two triplets at δH 0.81 (J 6.8 
Hz) and 2.28 (J 7.5 Hz), a broad singlet at δH 1.19 due to various CH2 fragments and a 
multiplet at δH 1.57. 
The 
13
C NMR spectrum (Plate 27) showed a carboxyl carbon signal at δC 178.5 and a 
methyl carbon signal at δC 14.1. Methylene carbon signals were observed in the region δC 




C NMR spectral data, compound 5.15 was 











5.4 Biological activity of the crude extracts and isolated compounds 
 
5.4.1 In vitro anticancer activity 
 
The crude extracts and isolated compounds were assayed in the three human cell line panel 
consisting of renal (TK10), melanoma (UACC62), and breast (MCF7) at the CSIR. 
In vitro assaying of the organic extract of E. tenuifolius showed that it had a moderate 
anticancer activity i.e. an average total growth inhibition (TGI) value of between 12.5 and 
15.5 µg/ml for all three cell lines (Fig. 5.13). This organic extract was subjected to 
bioassay-guided fractionation and five compounds were isolated and identified. Compound 
5.12 showed an increase in potency with TGI values of 2.73 µg/ml for renal cell line, 5.35 
µg/ml for melanoma and 4.82 µg/ml for breast cell line (Fig. 5.14). Compound 5.14 
showed selectivity for melanoma cell line with TGI value of 36.5 µg/ml (Fig. 5.16). No 





























Figure 5.18: Dose-response curve of tetracosanoic acid 5.16 
 
 
5.4.2 In vitro antiplasmodial activity and cytotoxicity of compound 5.12 
 
Compound 5.12 was tested for in vitro antiplasmodial activity against Plasmodium 
falciparum (CQS) D10 strain using the pLDH assay. The sensitivity of the D10 strain to 
chloroquine was also evaluated. The IC50 values are listed in Table 5.4.  
 
Table 5.4: In vitro antiplasmodial activity of chloroquine and compound 5.12 
Tested sample D10 IC50 (µg/ml) 
Chloroquine 11.96 x 10
-3 
Compound 5.12 6.25 
 
The in vitro results were classified as follows:  
IC50 value of ≤ 5 µg/ml, the compound was considered potent. 
IC50 value of between 5 and 10 µg/ml, the compound was considered moderately active. 
IC50 value of ≥ 10 µg/ml, the compound was considered weakly active. 
Based on these criteria, compound 5.12 can be considered moderately active against the 
parasite. 
 
The in vitro cytotoxicity of compound 5.12 was determined against Chinese Hamster 
Ovarian (CHO) cells using the MTT assay. The IC50 and SI values of the positive control 
emetine and compound 5.12 are shown in Table 5.5. 
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Table 5.5: In vitro cytotoxicity of Emetine and compound 5.12 
Tested sample CHO IC50 (µg/ml) SI
* 
Emetine 0.08 ND 
Chloroquine 18.53 1549 
Compound 5.12 5.72 1 
*Selectivity index (SI) = cytotoxicity IC50 / antiplasmodial IC50; ND = Not Done 
For the compound not to be toxic, SI values should be greater than 100.  
 
Compound 5.12 showed significant toxicity at the same concentration range against the 
CHO cell line and this is emphasized by its low SI value, so the observed antiplasmodial 





Of all compounds isolated from the aerial parts of E. tenuifolius, only 8-O-
isobutanoylcumambrin B 5.12 showed potent anticancer activity against a panel of three 
highly sensitive human cancer cell lines (breast MCF7, renal TK10 and melanoma 
UACC62) at the CSIR cancer screen. Compound 5.12 also showed moderate 
antiplasmodial activity against Plasmodium falciparum (CQS) D10 strain and toxicity to 
CHO cells. Although compound 5.12 has been isolated previously from other Eriocephalus 
species, there are no previous reports of the compound being investigated for any 
biological activity. 
 
The compounds pectolinagenin (5.13), hispidulin (5.14), friedelinol (5.15), and 
tetracosanoic acid (5.16), did not show any significant anticancer activity. All compounds 
isolated here are known compounds, but have not been previously reported as present from 











5.6.2 Plant Material 
 
The aerial parts of the plant were collected in February 2005 from Free State province in 
South Africa. The plant was identified by the South African National Biodiversity Institute 
(SANBI) in Pretoria as Eriocephalus tenuifolius DC. (Genspec number 315732) and the 
voucher specimen was deposited in the herbarium of SANBI. The aerial parts of the plant 
(10.0 kg) were oven dried at 50 
o
C for two days and milled to a coarse powder. 
 
 
5.6.3 Extraction and Isolation of Compounds 
 
The dried and ground plant material of E. tenuifolius (4.6 kg) was sequentially extracted 
with 1:1 (v/v) methanol/dichloromethane and purified water. The aqueous extract was 
concentrated by freeze-drying. The organic solvent was evaporated using a rotary vacuum 
evaporator at 60 
o
C and then further dried in a desiccator for five days. The resulting 
organic extract (30.5 g) was fractionated by column chromatography on silica gel using 2-
5% methanol/dichloromethane as eluant. Ten fractions (labelled 5A-J) were generated and 
fractionated as follows: Fraction 5A and B (1.5 g) were combined and flash 
chromatographed using 5-20% ethyl acetate/ hexane as eluant. Two compounds; 
compound 5.15 (4.5 mg) and compound 5.16 (7.8 mg) were isolated.  
 
Repeated flash chromatography of fraction 5C-D (5.5 g) using 5-40% ethyl acetate/ hexane 
as eluant yielded a semi purified compound. Further purification by preparative TLC (9:1 
chloroform/methanol) gave compound 5.13 (10.6 mg).  
Repeated flash chromatography and preparative TLC (40% ethyl acetate/hexane) of 
fraction 5F-G (10.2 g) led to the isolation of compound 5.12 (30.5 mg).  
Repeated flash chromatography and preparative TLC (9:1 chloroform/methanol) of 









5.6.4 Physical data 
 
5.6.4.1 Physical data for 8-O-isobutanoylcumambrin B (5.12) 
 
Physical description: white crystals 
Molecular formula: C19H26O5 
Yield: 30.5 mg 
ESI
-
TOF-MS m/z: 333.1693 




H NMR: Plate 8 
13
C NMR: Plate 9 
HSQC: Plate 10 
HMBC: Plate 11 
 
 
5.6.4.2 Physical data for pectolinarigenin (5.13) 
 
Physical description: yellow crystals 
Molecular formula: C17H14O6 
Yield: 10.6 mg 
ESI
-
-MS m/z: 313.10 




H NMR: Plate 12 
13
C NMR: Plate 13 
COSY: Plate 14 
HSQC: Plate 15 
HMBC: Plate 16 
NOESY: Plate 17 
 
 
5.6.4.3 Physical data for hispidulin (5.14) 
 
Physical description: yellow crystals 
Molecular formula: C16H12O6 
74 
 
Yield: 15.2 mg 
ESI
-
-MS m/z: 299.08 




H NMR: Plate 18 
13
C NMR: Plate 19 
COSY: Plate 20 
HSQC: Plate 21 
HMBC: Plate 22 
NOESY: Plate 23 
 
 
5.6.4.3 Physical data for friedelinol (5.15) 
 
Physical description: white crystals 
Molecular formula: C30H52O 
Yield: 4.5 mg 
GC-MS m/z: 428.4 




H NMR: Plate 24 
13
C NMR: Plate 25 
 
 
5.6.4.3 Physical data for tetracosanoic acid (5.16) 
 
Physical description: white crystals 
Molecular formula: C24H48O2 
Yield: 7.8 mg 
GC-MS m/z: 368.4 




H NMR: Plate 26 
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Cancer continues to be a public health problem worldwide and a major cause of death. The 
number of new cases, as well as the number of individuals living with cancer is expanding 
continuously. Plant-derived agents are being used for the treatment of cancer. Anticancer 
agents including taxol, vinblastine, vincristine, the camptothecin derivatives, topotecan and 
irinotecan, and etoposide derived from epipodophyllotoxin are in clinical use all over the 
world. With limited number of effective anticancer drugs from natural resources currently 
in use, there is a real need for new, safe, cheap and effective anticancer drugs to combat 
this dreaded and formidable disease. 
 
There are about 24 300 indigenous plants in South Africa and 3000 of these are reported to 
be used medicinal, but only a few have been described or studied. This unique resource 
remains untapped and could be the source of new drug leads and therefore a collaborative 
research programme was initiated between the CSIR and the NCI in the USA. 
 
In this study, two endemic plant species, Anthospermum hispidulum and Eriocephalus 
tenuifolius were investigated for their anticancer properties. The in vitro assaying of the 
organic extracts of these plant species, showed that they had moderate anticancer activity 
i.e. TGI value of < 15 μg/ml against a panel of three highly sensitive human cancer cell 
lines (breast, melanoma and renal). Bioassay-guided fractionation of the organic extracts of 
A. hispidulum led to the isolation of an active compound which was characterised as 
ursolic acid, and it is most likely that the activity observed in the organic extract can be 
attributed to this compound. Literature searches indicated that ursolic acid and its 
derivatives have been patented for their anticancer properties by Japanese scientists. 
 
Bioassay-guided fractionation of the organic extracts of E. tenuifolius resulted in the 
isolation of 8-O-isobutanoylcumambrin B as the active constituent. Although 8-O-
isobutanoylcumambrin B has been isolated previously from other Eriocephalus species, 
there are no previous reports of the compound being investigated for any biological 




activity. Structural modification of this compound to improve its potency and drugability 
can be recommended for further studies. 8-O-isobutanoylcumambrin B can be further 
developed as new anticancer drug lead. 
 
Bioassay-guided fractionation of these plant extracts, resulted in the isolation and 
identification of active ingredients, which could be used as scaffolds to develop leads with 
enhanced anticancer activity. The findings of the study have shown that South African 
plants can provide potential bioactive compounds for the development of new leads to 
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